PYC Therapeutics Limited (PYC) Price & Analysis

Compare

35 Followers

PYC Stock Chart & Stats

Day’s Range― - ―

52-Week RangeAU$0.95 - AU$2.09

Previous CloseN/A

Volume307.79K

Average Volume (3M)565.75K

Market Cap

AU$737.82M

Enterprise ValueAU$568.14M

Total Cash (Recent Filing)AU$49.25M

Total Debt (Recent Filing)AU$1.21M

Price to Earnings (P/E)―

Beta0.83

Next Earnings

Sep 02, 2025

EPS Estimate

-0.08

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.06

Shares Outstanding583,260,440

10 Day Avg. Volume642,228

30 Day Avg. Volume565,745

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

AU$2.07

Price Target Upside64.29% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering3

Bulls Say, Bears Say

Bulls Say

Clinical TrialsPYC-003 is now being assessed in a Phase I in healthy volunteers, entering a catalyst-rich period across all of its clinical programs.

Market ValidationNVS Acquisition of RGLS Further Validates MOA for Potentially Best-in-Class PYC-003.

ValuationPotential upside is noted, with the possibility of target price rising significantly if clinical results are positive.

Bears Say

Financial PerformanceThe upfront payment of US$7.00 per share infers an EV of US$0.8B – if applied to PYC’s capital structure, this generates a PYC valuation of AU$2.35 per share (US$1.50).

Probability Of SuccessApplying a 15% probability to the CVR, increases the valuation to AU$2.70 (US$1.72).

PYC Therapeutics Limited News

PYC Therapeutics Advances Clinical Trials for PKD Treatment

PYC Therapeutics Limited ( ($AU:PYC) ) has shared an announcement. PYC Therapeutics Limited has announced the progression of...

9d ago

PYC

PYC Therapeutics Updates Investors in Q3 Webinar

PYC Therapeutics Limited ( ($AU:PYC) ) has issued an update. PYC Therapeutics Limited held a Q3 investor webinar...

16d ago

PYC

PYC Therapeutics to Host Investor Webinar on Q3 Progress

PYC Therapeutics Limited ( ($AU:PYC) ) has shared an update. PYC Therapeutics Limited has announced an investor webinar...

20d ago

PYC

PYC Therapeutics Advances Drug Development Pipeline in Q2 2025

PYC Therapeutics Limited ( ($AU:PYC) ) has provided an announcement. PYC Therapeutics has made significant progress in its...

27d ago

PYC

PYC Therapeutics Advances Clinical Trials for PKD Treatment

PYC Therapeutics Limited ( ($AU:PYC) ) just unveiled an announcement. PYC Therapeutics has announced the progression of its...

1M ago

PYC

PYC Therapeutics Advances Phelan-McDermid Syndrome Program

PYC Therapeutics Limited ( ($AU:PYC) ) has provided an update. PYC Therapeutics announced progress in its Phelan-McDermid Syndrome...

2M ago

PYC

PYC Therapeutics Advances VP-001 with FDA Trial Design Approval

PYC Therapeutics Limited ( ($AU:PYC) ) has shared an announcement. PYC Therapeutics has received FDA alignment on the...

2M ago

PYC

PYC Therapeutics Advances ADOA Clinical Trial with Dose Escalation Approval

PYC Therapeutics Limited ( ($AU:PYC) ) has provided an announcement. PYC Therapeutics has received approval from the Safety...

2M ago

PYC

PYC Therapeutics Updates Investors in Q2 Webinar

PYC Therapeutics Limited ( ($AU:PYC) ) has shared an announcement. PYC Therapeutics Limited recently held a Q2 investor...

3M ago

PYC

PYC Therapeutics Advances Clinical Trial for PKD Treatment

The latest update is out from PYC Therapeutics Limited ( ($AU:PYC) ). PYC Therapeutics Limited has received approval...

3M ago

PYC

PYC FAQ

What was PYC Therapeutics Limited’s price range in the past 12 months?

PYC Therapeutics Limited lowest share price was AU$0.95 and its highest was AU$2.09 in the past 12 months.

What is PYC Therapeutics Limited’s market cap?

PYC Therapeutics Limited’s market cap is AU$737.82M.

When is PYC Therapeutics Limited’s upcoming earnings report date?

PYC Therapeutics Limited’s upcoming earnings report date is Sep 02, 2025 which is in 16 days.

How were PYC Therapeutics Limited’s earnings last quarter?

PYC Therapeutics Limited released its earnings results on Feb 27, 2025. The company reported -AU$0.055 earnings per share for the quarter, missing the consensus estimate of -AU$0.042 by -AU$0.013.

Is PYC Therapeutics Limited overvalued?

According to Wall Street analysts PYC Therapeutics Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does PYC Therapeutics Limited pay dividends?

PYC Therapeutics Limited does not currently pay dividends.

What is PYC Therapeutics Limited’s EPS estimate?

PYC Therapeutics Limited’s EPS estimate is -0.08.

How many shares outstanding does PYC Therapeutics Limited have?

PYC Therapeutics Limited has 583,260,440 shares outstanding.

What happened to PYC Therapeutics Limited’s price movement after its last earnings report?

PYC Therapeutics Limited reported an EPS of -AU$0.055 in its last earnings report, missing expectations of -AU$0.042. Following the earnings report the stock price went up 3.279%.

Which hedge fund is a major shareholder of PYC Therapeutics Limited?

Currently, no hedge funds are holding shares in AU:PYC

PYC Therapeutics Limited Stock Smart Score

Underperform

Fundamentals

Return on Equity

-112.97%

Trailing 12-Months

Asset Growth

71.61%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

PYC Therapeutics Limited

PYC Therapeutics Limited (PYC) is a biotechnology company focused on the development of innovative therapies for the treatment of genetic diseases. The company operates in the biopharmaceutical sector, leveraging its proprietary drug delivery platforms to create precision medicines. PYC's core products include RNA-based therapeutics designed to target and correct genetic mutations at their source, offering potential treatments for a range of inherited disorders.

PYC Therapeutics Limited (PYC) Earnings & Revenues

Historic Earnings Reports

PYC Stock 12 Month Forecast

Average Price Target

AU$2.07

▲(64.29% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"AU$0","1":"AU$1","2":"AU$2","3":"AU$3","-1":"-AU$1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$2.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.07,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$2.07</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$1.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0,1,2,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Oct<br/>2024","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.3,1.3846153846153846,1.4692307692307693,1.5538461538461539,1.6384615384615384,1.7230769230769232,1.8076923076923077,1.8923076923076922,1.976923076923077,2.0615384615384613,2.146153846153846,2.230769230769231,2.315384615384615,{"y":2.4,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.3,1.3592307692307692,1.4184615384615384,1.4776923076923076,1.5369230769230768,1.596153846153846,1.6553846153846155,1.7146153846153847,1.7738461538461539,1.833076923076923,1.8923076923076922,1.9515384615384614,2.0107692307692306,{"y":2.07,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.3,1.3153846153846154,1.3307692307692307,1.3461538461538463,1.3615384615384616,1.376923076923077,1.3923076923076922,1.4076923076923078,1.4230769230769231,1.4384615384615385,1.4538461538461538,1.4692307692307693,1.4846153846153847,{"y":1.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.76,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.84,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.04,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.19,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.95,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.29,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.69,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.89,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.31,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.18,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.24,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.2,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.3,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >